Baseline and Treatment Characteristics of the 253 Tuberculosis Patients Included in the Study, According to Length of Follow-up/Survival and Duration of Anti-tuberculosis Therapy.

<p>Data are presented as number (%) except as shown.</p><p>P-values are for the comparison of all 4 groups, using the chi-squared test.</p><p>* the comparison limited to persons with > 6 months of follow-up and known TB treatment duration (the two inner columns) was not statistically significant. If not noted by * the statistical significance of the comparison between these two groups was similar to that of all 4 groups.</p><p>=Data available for 222 patients.</p><p>^ Data available for 222 patients.</p><p># Data available for 171 patients.</p><p>+ Data available for 228 patients.</p><p>a median time between TB diagnosis and ART start: 95 days (IQR: 53, 142)</p><p>b median time between ART start and TB diagnosis: 142 days (IQR: 30, 568)